ArticleCancers2023

Efficacy and Safety of Daratumumab, Pomalidomide, and Dexamethasone (DPd) Compared to Daratumumab, Bortezomib, and Dexamethasone (DVd) in Daratumumab-Naïve Relapsed Multiple Myeloma.

Aimaz Afrough et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.